Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
Study NCT ID:
NCT01605318
Status:
TERMINATED
Last Update Posted:
2024-01-24
First Post:
2012-05-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-22
First Submit QC Date:
None
Study First Post Date:
2012-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-01-24
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-01-22
Last Update Post Date:
2024-01-24
Last Update Post Date Type:
ACTUAL